Full Text
The Full Text of this article is available as a PDF (25.4 KB).
Footnotes
Membership of the Biomarkers Group comprises: Professor Robin Leake (Biochemistry, Glasgow University – Chairman), Dr Liz Anderson (Clinical Research, Christie Hospital, Manchester), Professor Mitch Dowsett (Endocrinology, Royal Marsden Hospital, London), Dr Ray Iles (St Bartholomew's Hospital, London), Professor Rob Nicholson, Tenovus Unit, Pharmacology, Cardiff), Professor John Robertson (Surgery, Nottingham), Dr Rosemary Walker (Pathology, Leicester).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barnes D. M., Millis R. R., Beex L. V., Thorpe S. M., Leake R. E. Increased use of immunohistochemistry for oestrogen receptor measurement in mammary carcinoma: the need for quality assurance. Eur J Cancer. 1998 Oct;34(11):1677–1682. doi: 10.1016/s0959-8049(98)00149-x. [DOI] [PubMed] [Google Scholar]
- Elledge R. M., Osborne C. K. Oestrogen receptors and breast cancer. BMJ. 1997 Jun 28;314(7098):1843–1844. doi: 10.1136/bmj.314.7098.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hayes D. F., Bast R. C., Desch C. E., Fritsche H., Jr, Kemeny N. E., Jessup J. M., Locker G. Y., Macdonald J. S., Mennel R. G., Norton L. Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers. J Natl Cancer Inst. 1996 Oct 16;88(20):1456–1466. doi: 10.1093/jnci/88.20.1456. [DOI] [PubMed] [Google Scholar]
- Mander B. J., Heal K., Porushotham A. D., Wishart G. C. Oestrogen-receptor status in management of breast cancer in UK. Lancet. 1998 Jul 4;352(9121):36–37. doi: 10.1016/s0140-6736(05)79517-9. [DOI] [PubMed] [Google Scholar]
- Romain S., Lainé Bidron C., Martin P. M., Magdelenat H. Steroid receptor distribution in 47,892 breast cancers. A collaborative study of 7 European laboratories. The EORTC Receptor Study Group. Eur J Cancer. 1995;31A(3):411–417. doi: 10.1016/0959-8049(94)00496-r. [DOI] [PubMed] [Google Scholar]
- Schmitt M., Harbeck N., Thomssen C., Wilhelm O., Magdolen V., Reuning U., Ulm K., Höfler H., Jänicke F., Graeff H. Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy. Thromb Haemost. 1997 Jul;78(1):285–296. [PubMed] [Google Scholar]
- Stål O., Sullivan S., Wingren S., Skoog L., Rutqvist L. E., Carstensen J. M., Nordenskjöld B. c-erbB-2 expression and benefit from adjuvant chemotherapy and radiotherapy of breast cancer. Eur J Cancer. 1995 Dec;31A(13-14):2185–2190. doi: 10.1016/0959-8049(95)00344-4. [DOI] [PubMed] [Google Scholar]